Delamaire M, Bernard M D, Boisseau M R
Centre Régional de Transfusion Sanguine, Rennes, France.
Blood Press Suppl. 1995;3:58-61.
There is an increased prevalence of blood hyperviscosity in patients with arterial hypertension, and viscosity changes are related to hypertensive organ damage such as e.g. left ventricular hypertrophy. Various indices of hemorheology may be assessed in studies of hypertensive patients, most commonly viscosity, erythrocyte filtration, erythrocyte aggregation, platelet aggregation, etc. In vitro assessment of erythrocyte deformability and adrenaline induced platelet aggregation was performed after urapidil administration. Increasing concentrations of urapidil (25-150 microM) caused a dose dependent improvement of the erythrocyte rigidity index as well as inhibited adrenaline induced platelet aggregation. The beneficial effects of urapidil on hemorheology could add to its therapeutic effects in the treatment of arterial hypertension.
动脉高血压患者血液高黏滞度的患病率增加,且黏度变化与高血压性器官损害有关,如左心室肥厚。在高血压患者的研究中可评估各种血液流变学指标,最常见的是黏度、红细胞滤过、红细胞聚集、血小板聚集等。在给予乌拉地尔之后,进行了红细胞变形性和肾上腺素诱导的血小板聚集的体外评估。乌拉地尔浓度增加(25 - 150微摩尔)导致红细胞刚性指数呈剂量依赖性改善,并抑制肾上腺素诱导的血小板聚集。乌拉地尔对血液流变学的有益作用可能会增加其在治疗动脉高血压中的治疗效果。